Platelet integrin α(IIb)β3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 156-163

  Pedreño, Javier ^a,b   Fernández, Rosa ^a   Cullaré, Cristina ^b   Barceló, Antonia ^a   Elorza, Miguel Angel ^a   De Castellarnau, Conxita ^b  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

binding site; lipoprotein(a); oxidized lipoproteins; platelet integrin (IIb) 3

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRONECTIN; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; INTEGRIN; LIPOPROTEIN A; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; VITRONECTIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; DISSOCIATION CONSTANT; GLANZMANN DISEASE; HUMAN; HUMAN CELL; LIGAND BINDING; MEMBRANE BINDING; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0031033625     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.156     Document Type: Article

References (28)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
2. Badimon JJ, Badimon L, Turitto VT, Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels: in vivo study in the rabbit model. Arterioscler Thromb. 1991;11:395-402.
3. Cadroy Y, Lemozy S, Diquélou A, Ferrières J, Douste-Blazy P, Boneu B, Sakariaseen KS. Human type II hyperlipoproteinemia enhances platelet-collagen adhesion in flowing nonanticoagulated blood. Arterioscler Thromb. 1993;13:1650-1653.
4. Andrews HE, Aitken JW, Hassall DG, Skinner VO, Bruckdofer KR. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem J. 1987;242:550-564.
5. Koller E, Koller F, Doleschel W. Specific binding sites on human blood platelets for plasma lipoproteins. Hoppe-Seylers Z Pliysiol Chem. 1982;363:395-405.
6. Aviram M, Brook JG. Platelet interaction with high and low density lipoproteins. Atherosclerosis. 1983;46:259-268.
7. Mazurov AV, Preobrazhensky SN, Leytin VL, Repin VS, Smirnov VN. Study of low density lipoprotein interaction with platelets by flow cytofluorometry. FEBS Lett. 1982;137:319-322.
8. Aviram M, Brook JG. Platelet activation by plasma lipoproteins. Prog Cardiovasc Dis. 1987;30:61-72.
9. Curtiss LK, Plow EF. Interaction of plasma lipoproteins with human platelets. Blood. 1984;64:365-374.
10. Koller E. Lipoprotein-binding proteins in the human platelet plasma membrane. FEBS Lett. 1986;200:97-102.
11. Koller E, Koller F, Binder B. Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane. J Biol Chem. 1989;264:12412-12418.
12. Pedreño J, de Castellarnau C, Cullaré C, Sánchez J, Gómez-Gerique J, Ordoñez-Llanos J, González-Sastre F. LDL binding sites on platelets differ from the 'classical' receptor of nucleated cells. Arterioscler Thromb. 1992;12:1353-1362.
13. Pedreño J, de Castellarnau C, Cullaré C, Ortín R, Sánchez JL, Llopart R, González-Sastre F. Platelet LDL receptor recognizes with the same apparent affinity both oxidized and native LDL: evidence that the receptor-ligand complexes are not internalized. Arterioscler Thromb. 1994;14:401-408.
14. Koller E, Koller F. Binding characteristics of homologous plasma lipoproteins to human platelets. Methods Enzymol. 1992;215:383-398.
15. 2+-mobilizing activity of low density lipoproteins. Atherosclerosis. 1992;96:119-124.
16. 111In-labeled LDL to platelets of normolipemic volunteers and patients with heterozygous familial hypercholesterolemia. Arterioscler Thromb. 1993;13:536-547.
17. Malle E, Sattler W. Platelets and the lipoproteins: native, modified and platelet modified lipoproteins. Platelets. 1994;5:70-83.
18. Zhao B, Dierichs R, Liu B, Berkes P. Gold-labelled low density lipoproteins bind to washed human platelets. Platelets. 1994;5:113-120.
19. Ezratty A, Simon DI, Loscalzo J. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry. 1993:32:4628-4633.
20. Malle E, Ibovnik A, Steinmetz A, Kostner GM, Sattler W. Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets: lipoprotein(a) binding is independent of an arginyl-glycyl-aspartate tripeptide located in apolipoprotein(a). Arterioscler Thromb. 1994;14:345-352.
21. van Willigen G, Gorter G, Akkerman J-WN. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules. Arterioscler Thromb. 1994;14:41-46.
22. Pedreño J, Fernández R. Proteolytic susceptibility of platelet LDL receptor. Lipids. 1995;30:927-933.
23. Koller E, Volf I, Koller F. Binding of low density lipoprotein to human platelets: effects of chymotrypsin. Thromb Haemorrh Disorders. 1992;6:57-65.
24. Hassall DG, Owen JS, Bruckdorfer KR. The aggregation of isolated platelets in the presence of lipoproteins and prostacyclin. Biochem J. 1983;216:43-49.
25. Hassall DG, Forrest LA, Bruckdorfer KB. Influence of plasma lipoproteins on platelet aggregation in a normal male population. Arteriosclerosis. 1983;3:332-338.
26. Aviram M, Brook JG. Characterization of the effect of plasma lipoprotein on platelet function in vitro. Haemostasis. 1983;13:344-350.
27. Malle E, Satller W, Prenner E, Leis HJ, Hermetter A, Dries A, Kostner GM. Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations. Atherosclerosis. 1991;88:193-201.
28. Calvete JJ, Rivas G, Maruri M, Alvarez M, McGregor JL, Hew CL, González-Rodriguez J. Tryptic fragment of human GP IIIa: isolation and biochemical characterization of the 23 kDa N-terminal glycopeptide carrying the antigenic determinant for a monoclonal antibody (P37) which inhibits platelet aggregation. Biochem J. 1988;260:697-704.